Financhill
Back

Citizens Financial Services Vs. Axsome Therapeutics Industry Stock Comparison

Sell
45

CZFS
Citizens Financial Services

Last Price:
$53.80
Seasonality Move:
2.05%
Sell
37

AXSM
Axsome Therapeutics

Last Price:
$107.89
Seasonality Move:
19.74%
Sell
45
Citizens Financial Services (CZFS) is a Sell

Is Citizens Financial Services a Buy, Sell or Hold?

  • The current Citizens Financial Services [CZFS] share price is $58.97. The Score for CZFS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CZFS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $109.75. The Score for AXSM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CZFS Stock Price Chart

What is Citizens Financial Services's stock price today?

  • The Citizens Financial Services share price today is $58.97
    The current trend is moderately bullish and CZFS is experiencing buying pressure, which is a positive indicator for future bullish movement.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $109.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.

CZFS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.08 Buy
Relative Strength Index (14 RSI): 50.38 Buy
Chaikin Money Flow: 17028 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.04 - 59.94) Buy
Bollinger Bands (100): (58.65 - 68.47) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.51 Sell
Relative Strength Index (14 RSI): 34.09 Sell
Chaikin Money Flow: -196956 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (117.79 - 127.47) Sell
Bollinger Bands (100): (89.81 - 121.33) Buy

CZFS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.56 Buy
20-day SMA: 58.15 Buy
50-day SMA: 60.23 Sell
200-day SMA: 57.43 Buy
8-day EMA: 53.74 Buy
20-day EMA: 37.01 Buy
50-day EMA: 19.3 Buy
200-day EMA: 5.57 Buy

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.38 Sell
20-day SMA: 121.53 Sell
50-day SMA: 118.82 Sell
200-day SMA: 95.87 Buy
8-day EMA: 116.81 Sell
20-day EMA: 120.13 Sell
50-day EMA: 116.68 Sell
200-day EMA: 99.37 Buy

Citizens Financial Services Earnings Growth & CZFS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.03 per share, an increase this year of $1.09 per share, and an increase next year of $0.35 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.

Citizens Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):